Finalized: $7.25 Billion Bayer Settlement Resolves Roundup Cancer Litigation
A Missouri court officially approved Bayer's $7.25 billion deal, ending years of Roundup cancer lawsuits and reshaping future glyphosate litigation.
POLICY WIRE — St. Louis, United States — A federal judge has formally sanctioned the landmark $7.25 billion agreement between Bayer and plaintiffs alleging that Roundup weed killer contributed to cancer diagnoses.
The judicial approval marks the definitive end to this massive class action, which had drawn attention from national and international media outlets, including PBS, The New York Times, and the BBC.
Reuters confirmed that the Missouri-based court signed off on the terms of the settlement, a move that significantly limits the legal avenues available for future glyphosate-related claims.
Legal analysts noted that this ruling makes it considerably more difficult for individuals to pursue additional lawsuits against the agrochemical giant over similar personal injury allegations.
The decision consolidates a sprawling legal dispute into a single financial resolution, providing a clear endpoint to the litigation that involved hundreds of thousands of claimants.
Reporting by Policy-Wire (PW)



